News

Published on 16 Mar 2024 on Insider Monkey via Yahoo Finance

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript


Article preview image

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript March 13, 2024

Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-4.3 EPS, expectations were $-0.26. ANIK isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good evening, ladies and gentlemen, and welcome to Anika's Fourth Quarter and Year-End 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator instructions] I will now turn the call over to Mark Namaroff, Vice President, Investor Relations, ESG, and Corp Communications. Please proceed.

NASDAQ.ANIK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock...

Many investors define successful investing as beating the market average over the long term. But ...

Simply Wall St. via Yahoo Finance 25 Apr 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript March 13, 2024 Anika Ther...

Insider Monkey via Yahoo Finance 16 Mar 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript November 3, 2023 Operator...

Insider Monkey via Yahoo Finance 5 Nov 2023

Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance

<img src=https://s.yimg.com/ny/api/res/1.2/3mE5g4hcs4lnTiynmJC4Cg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2M...

GuruFocus.com via Yahoo Finance 2 Nov 2023

Anika Therapeutics, Inc. (NASDAQ:ANIK) is favoured by institutional owners who hold 66% of the...

Key Insights Institutions' substantial holdings in Anika Therapeutics implies that they have sign...

Simply Wall St. via Yahoo Finance 23 Oct 2023

Investors in Anika Therapeutics (NASDAQ:ANIK) have unfortunately lost 52% over the last five years

We think intelligent long term investing is the way to go. But along the way some stocks are goin...

Simply Wall St. via Yahoo Finance 6 Oct 2023

Apellis (APLS) Provides Syfovre Q3 Preliminary Revenues Guidance

Apellis Pharmaceuticals APLS provided third-quarter 2023 preliminary revenues guidance for its re...

Zacks via Yahoo Finance 6 Oct 2023

Structure Therapeutics (GPCR) Stock Up 9% This Week: Here's Why

Structure Therapeutics’ GPCR shares were up 9.1 % this week, owing to a positive announcement las...

Zacks via Yahoo Finance 6 Oct 2023

Intellia (NTLA), Regeneron Expand Deal for Gene-Editing Therapies

Intellia Therapeutics NTLA announced that it has expanded its existing collaboration with Regener...

Zacks via Yahoo Finance 4 Oct 2023

Caligan Partners LP Boosts Stake in Anika Therapeutics Inc

Caligan Partners LP, a New York-based investment firm, has recently increased its holdings in Ani...

GuruFocus.com via Yahoo Finance 17 Aug 2023